ArticleMolecules (Basel, Switzerland)2022

Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor.

Meirambek Ospanov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.